Limit search to available items
Nearby Subjects are:
Result Page   Prev Next
Add Marked to Bag Add All On Page Add Marked to My Lists
Mark   Year Entries
Vaccines -- Health aspects.   10
 

Vaccines, Hepatitis A -- See Hepatitis A Vaccines


Vaccines or candidate vaccines used to prevent infection with hepatitis A virus (HEPATOVIRUS)
  1
 

Vaccines, Hepatitis B -- See Hepatitis B Vaccines


Vaccines or candidate vaccines containing inactivated hepatitis B or some of its component antigens and designed to prevent hepatitis B. Some vaccines may be recombinantly produced
  1
 

Vaccines, Hepatovirus -- See Hepatitis A Vaccines


Vaccines or candidate vaccines used to prevent infection with hepatitis A virus (HEPATOVIRUS)
  1
Vaccines -- history.   8
 

Vaccines, HSV -- See Herpes Simplex Virus Vaccines


Vaccines or candidate vaccines used to prevent infection with viruses from the genus SIMPLEXVIRUS. This includes vaccines for HSV-1 and HSV-2
  1
 

Vaccines, Human Papillomavirus -- See Papillomavirus Vaccines


Vaccines or candidate vaccines used to prevent PAPILLOMAVIRUS INFECTIONS. Human vaccines are intended to reduce the incidence of UTERINE CERVICAL NEOPLASMS, so they are sometimes considered a type of CANCER VACCINES. They are often composed of CAPSID PROTEINS, especially L1 protein, from various types of ALPHAPAPILLOMAVIRUS
  1
Vaccines -- immunology.   15
Vaccines industry.   11
Vaccines industry -- Australia -- Periodicals. : Annual report  1991- 1
Vaccines industry -- Corrupt practices -- United States. : Evidence of harm : mercury in vaccines and the autism epidemic : a medical controversy / David Kirby  2005 1
Vaccines industry -- Forecasting. : Biodefense and special pathogen vaccines in development : part 1 of 2 / Gerald R. Kovacs  2015 1
Vaccines industry -- Government policy -- United States.   3
Vaccines industry -- Risk management. : Roche and Tamifluʼ doing business in the shadow of pandemic / doing business in the shadow of pandemic / Timothy J. Feddersen, Jochen Gottschalk, Lars Peters  2007 1
Vaccines industry -- United States -- Decision making.   3
Vaccines -- isolation & purification.   14
Vaccines -- Laboratory manuals. : Vaccine development and manufacturing / edited by Emily P. Wen, Ronald J. Ellis, Narahari S. Pujar  2015 1
 

Vaccines, Live, Attenuated -- See Vaccines, Attenuated


Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity
  1
 

Vaccines, Malaria -- See Malaria Vaccines


Vaccines made from antigens arising from any of the four strains of Plasmodium which cause malaria in humans, or from P. berghei which causes malaria in rodents
  1
 

Vaccines, Malarial -- See Malaria Vaccines


Vaccines made from antigens arising from any of the four strains of Plasmodium which cause malaria in humans, or from P. berghei which causes malaria in rodents
  1
 

Vaccines, Meningococcal -- See Meningococcal Vaccines


Vaccines or candidate vaccines used to prevent infection with NEISSERIA MENINGITIDIS
  1
 

Vaccines, Molecular -- See Vaccines, Synthetic


Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified
  1
 

Vaccines, Monovalent Influenza -- See Influenza Vaccines


Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more INFLUENZAVIRUS A and INFLUENZAVIRUS B strains
  1
 

Vaccines, Naked DNA -- See Vaccines, DNA


Recombinant DNA vectors encoding antigens administered for the prevention or treatment of disease. The host cells take up the DNA, express the antigen, and present it to the immune system in a manner similar to that which would occur during natural infection. This induces humoral and cellular immune responses against the encoded antigens. The vector is called naked DNA because there is no need for complex formulations or delivery agents; the plasmid is injected in saline or other buffers
  1
 

Vaccines, Neoplasm -- See Cancer Vaccines


Vaccines or candidate vaccines designed to prevent or treat cancer. Vaccines are produced using the patient's own whole tumor cells as the source of antigens, or using tumor-specific antigens, often recombinantly produced
  1
 

Vaccines, Nucleic Acid -- See Vaccines, DNA


Recombinant DNA vectors encoding antigens administered for the prevention or treatment of disease. The host cells take up the DNA, express the antigen, and present it to the immune system in a manner similar to that which would occur during natural infection. This induces humoral and cellular immune responses against the encoded antigens. The vector is called naked DNA because there is no need for complex formulations or delivery agents; the plasmid is injected in saline or other buffers
  1
 

Vaccines, Papillomavirus -- See Papillomavirus Vaccines


Vaccines or candidate vaccines used to prevent PAPILLOMAVIRUS INFECTIONS. Human vaccines are intended to reduce the incidence of UTERINE CERVICAL NEOPLASMS, so they are sometimes considered a type of CANCER VACCINES. They are often composed of CAPSID PROTEINS, especially L1 protein, from various types of ALPHAPAPILLOMAVIRUS
  1
 

Vaccines, Peptide -- See Vaccines, Subunit


Vaccines consisting of one or more antigens that stimulate a strong immune response. They are purified from microorganisms or produced by recombinant DNA techniques, or they can be chemically synthesized peptides
  1
Vaccines -- Periodicals   14
Vaccines -- pharmacology.   6
 

Vaccines, Pneumococcal -- See Pneumococcal Vaccines


Vaccines or candidate vaccines used to prevent infections with STREPTOCOCCUS PNEUMONIAE
  1
 

Vaccines, Poliovirus -- See Poliovirus Vaccines


Vaccines used to prevent POLIOMYELITIS. They include inactivated (POLIOVIRUS VACCINE, INACTIVATED) and oral vaccines (POLIOVIRUS VACCINE, ORAL)
  1
Vaccines -- Political aspects -- Africa, West. : Vaccine anxieties : global science, child health, and society / Melissa Leach and James Fairhead  2007 1
Vaccines -- Political aspects -- Great Britain. : Vaccine anxieties : global science, child health, and society / Melissa Leach and James Fairhead  2007 1
 

Vaccines, Polynucleotide -- See Vaccines, DNA


Recombinant DNA vectors encoding antigens administered for the prevention or treatment of disease. The host cells take up the DNA, express the antigen, and present it to the immune system in a manner similar to that which would occur during natural infection. This induces humoral and cellular immune responses against the encoded antigens. The vector is called naked DNA because there is no need for complex formulations or delivery agents; the plasmid is injected in saline or other buffers
  1
Vaccines -- Popular works.   3
 

Vaccines Products liability -- See Products liability Vaccines


  1
Products liability -- Vaccines -- United States. : Vaccine court : the law and politics of injury / Anna Kirkland  2017 1
 

Vaccines, Pseudorabies -- See Pseudorabies Vaccines


Vaccines or candidate vaccines used to prevent PSEUDORABIES (Aujeszky's disease), a herpesvirus of swine and other animals
  1
 

Vaccines, Rabies -- See Rabies Vaccines


Vaccines or candidate vaccines used to prevent and treat RABIES. The inactivated virus vaccine is used for preexposure immunization to persons at high risk of exposure, and in conjunction with rabies immunoglobulin, for postexposure prophylaxis
  1
 

Vaccines, Recombinant -- See Vaccines, Synthetic


Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified
  1
 

Vaccines, Recombinant DNA -- See Vaccines, DNA


Recombinant DNA vectors encoding antigens administered for the prevention or treatment of disease. The host cells take up the DNA, express the antigen, and present it to the immune system in a manner similar to that which would occur during natural infection. This induces humoral and cellular immune responses against the encoded antigens. The vector is called naked DNA because there is no need for complex formulations or delivery agents; the plasmid is injected in saline or other buffers
  1
Vaccines -- Research.   24
Vaccines -- Research -- Congresses. : Research strategies for assessing adverse events associated with vaccines : a workshop summary / Committee to Study New Research on Vaccines, Division of Health Promotion and Disease Prevention, Institute of Medicine ; Kathleen R. Stratton, Cynthia J. Howe, and Richard B. Johnston, Jr., editors  1994 1
Vaccines -- Research -- Economic aspects -- Developing countries. : Strong medicine : creating incentives for pharmaceutical research on neglected diseases / Michael Kremer and Rachel Glennerster  2004 1
Vaccines -- Research -- Government policy. : New vaccine development : establishing priorities. Volume II, Diseases of importance in Developing Countries / part two of a two-part Study by the Committee on Issues and Priorities for New Vaccine Development, Division of Health Promotion and Disease Prevention, and Division of International Health, Institute of Medicine  1986 1
Vaccines -- Research -- Periodicals.   2
Vaccines -- Research -- United States -- History. : Vaccinated : one man's quest to defeat the world's deadliest diseases / Paul A. Offit  2007 1
 

Vaccines, RSV -- See Respiratory Syncytial Virus Vaccines


Vaccines or candidate vaccines used to prevent infection with RESPIRATORY SYNCYTIAL VIRUSES
  1
Vaccines -- Safety measures.   2
Add Marked to Bag Add All On Page Add Marked to My Lists
Result Page   Prev Next